Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$62.73
1.282.09%
At close: -
$62.73
0.000.00%
After Hours: 7:50 PM EDT
Comments
Loading...
Rhythm Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:RYTM | Benzinga
Rhythm Pharmaceuticals Inc has a consensus price target of $71.43 based on the ratings of 14 analysts. The high is $94 issued by Stifel on May 29, 2025. The low is $35 issued by Ladenburg Thalmann on March 2, 2023. The 3 most-recent analyst ratings were released by JMP Securities, Stifel, and Needham on June 26, 2025, May 29, 2025, and May 7, 2025, respectively. With an average price target of $83.33 between JMP Securities, Stifel, and Needham, there's an implied 32.84% upside for Rhythm Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
Stifel
Needham
B of A Securities
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Rhythm Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/26/2025 | Buy Now | 33.91% | JMP Securities | Jonathan Wolleben71% | $84 → $84 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/29/2025 | Buy Now | 49.85% | Stifel | Paul Matteis43% | $78 → $94 | Maintains | Buy | Get Alert |
| 05/07/2025 | Buy Now | 14.78% | Needham | Joseph Stringer64% | $66 → $72 | Maintains | Buy | Get Alert |
| 04/10/2025 | Buy Now | 8.4% | B of A Securities | Tazeen Ahmad56% | $63 → $68 | Maintains | Buy | Get Alert |
| 04/08/2025 | Buy Now | 27.53% | HC Wainwright & Co. | Raghuram Selvaraju44% | $70 → $80 | Reiterates | Buy → Buy | Get Alert |
| 04/08/2025 | Buy Now | 46.66% | Canaccord Genuity | Whitney Ijem56% | $81 → $92 | Maintains | Buy | Get Alert |
| 04/08/2025 | Buy Now | 5.21% | Needham | Joseph Stringer64% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 04/07/2025 | Buy Now | 45.07% | Wells Fargo | Derek Archila62% | $80 → $91 | Maintains | Overweight | Get Alert |
| 03/24/2025 | Buy Now | 11.59% | HC Wainwright & Co. | Raghuram Selvaraju44% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2025 | Buy Now | 5.21% | Needham | Joseph Stringer64% | $64 → $66 | Maintains | Buy | Get Alert |
| 03/07/2025 | Buy Now | 14.78% | Morgan Stanley | Jeffrey Hung51% | $72 → $72 | Assumes | → Overweight | Get Alert |
| 03/05/2025 | Buy Now | 24.34% | Stifel | Paul Matteis43% | → $78 | Reinstates | → Buy | Get Alert |
| 03/03/2025 | Buy Now | 11.59% | HC Wainwright & Co. | Raghuram Selvaraju44% | $69 → $70 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 29.12% | Canaccord Genuity | Whitney Ijem56% | $80 → $81 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 2.02% | Needham | Joseph Stringer64% | $64 → $64 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | 2.02% | Needham | Joseph Stringer64% | $64 → $64 | Reiterates | Buy → Buy | Get Alert |
| 02/19/2025 | Buy Now | 2.02% | Needham | Joseph Stringer64% | $64 → $64 | Reiterates | Buy → Buy | Get Alert |
| 12/23/2024 | Buy Now | 19.56% | JMP Securities | Jonathan Wolleben71% | $75 → $75 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/23/2024 | Buy Now | 10% | HC Wainwright & Co. | Raghuram Selvaraju44% | $69 → $69 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2024 | Buy Now | 21.15% | Oppenheimer | Leland Gershell69% | → $76 | Initiates | → Outperform | Get Alert |
| 12/05/2024 | Buy Now | 5.21% | Goldman Sachs | Corinne Jenkins47% | $59 → $66 | Maintains | Buy | Get Alert |
| 12/04/2024 | Buy Now | 10% | HC Wainwright & Co. | Raghuram Selvaraju44% | $69 → $69 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | 10% | HC Wainwright & Co. | Raghuram Selvaraju44% | $69 → $69 | Reiterates | Buy → Buy | Get Alert |
| 11/19/2024 | Buy Now | 27.53% | Canaccord Genuity | Whitney Ijem56% | $80 → $80 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 10% | HC Wainwright & Co. | Raghuram Selvaraju44% | $64 → $69 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 27.53% | Canaccord Genuity | Whitney Ijem56% | $77 → $80 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 3.62% | TD Cowen | Phil Nadeau66% | $55 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 2.02% | Needham | Joseph Stringer64% | $55 → $64 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | -12.32% | Needham | Joseph Stringer64% | $55 → $55 | Reiterates | Buy → Buy | Get Alert |
| 10/25/2024 | Buy Now | 2.02% | HC Wainwright & Co. | Raghuram Selvaraju44% | $64 → $64 | Reiterates | Buy → Buy | Get Alert |
| 10/21/2024 | Buy Now | 11.59% | Guggenheim | Seamus Fernandez67% | → $70 | Initiates | → Buy | Get Alert |
| 10/14/2024 | Buy Now | -17.11% | B of A Securities | Tazeen Ahmad56% | $48 → $52 | Maintains | Neutral | Get Alert |
| 10/07/2024 | Buy Now | 2.02% | HC Wainwright & Co. | Raghuram Selvaraju44% | $64 → $64 | Reiterates | Buy → Buy | Get Alert |
| 09/18/2024 | Buy Now | 2.02% | HC Wainwright & Co. | Raghuram Selvaraju44% | → $64 | Initiates | → Buy | Get Alert |
| 09/17/2024 | Buy Now | 2.02% | JMP Securities | Jonathan Wolleben71% | → $64 | Initiates | → Market Outperform | Get Alert |
| 08/07/2024 | Buy Now | -12.32% | Needham | Joseph Stringer64% | $55 → $55 | Reiterates | Buy → Buy | Get Alert |
| 07/25/2024 | Buy Now | -12.32% | Needham | Joseph Stringer64% | $46 → $55 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 25.94% | Canaccord Genuity | Whitney Ijem56% | $80 → $79 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | -33.05% | B of A Securities | Tazeen Ahmad56% | $49 → $42 | Downgrade | Buy → Neutral | Get Alert |
| 05/07/2024 | Buy Now | -26.67% | Needham | Joseph Stringer64% | $50 → $46 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | -20.29% | Needham | Joseph Stringer64% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 04/18/2024 | Buy Now | -17.11% | Wells Fargo | Derek Archila62% | $53 → $52 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | -20.29% | Needham | Joseph Stringer64% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 02/22/2024 | Buy Now | -20.29% | Needham | Joseph Stringer64% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 01/26/2024 | Buy Now | -20.29% | Needham | Joseph Stringer64% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 01/26/2024 | Buy Now | -17.11% | Goldman Sachs | Corinne Jenkins47% | $42 → $52 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | -17.11% | Goldman Sachs | Corinne Jenkins47% | $42 → $52 | Maintains | Buy | Get Alert |
| 01/04/2024 | Buy Now | -20.29% | Needham | Joseph Stringer64% | $45 → $50 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | -12.32% | Morgan Stanley | Jeffrey Hung51% | $29 → $55 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/19/2023 | Buy Now | -15.51% | Wells Fargo | Derek Archila62% | $48 → $53 | Maintains | Overweight | Get Alert |
| 12/07/2023 | Buy Now | -33.05% | Goldman Sachs | Corinne Jenkins47% | $38 → $42 | Maintains | Buy | Get Alert |
| 12/07/2023 | Buy Now | -28.26% | Needham | Joseph Stringer64% | $32 → $45 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | -36.23% | Wells Fargo | Derek Archila62% | $38 → $40 | Maintains | Overweight | Get Alert |
| 10/10/2023 | Buy Now | -53.77% | Morgan Stanley | Jeffrey Hung51% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | -55.36% | Morgan Stanley | Jeffrey Hung51% | $28 → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | -56.96% | B of A Securities | Tazeen Ahmad56% | $22 → $27 | Upgrade | Neutral → Buy | Get Alert |
| 08/02/2023 | Buy Now | -48.99% | Needham | Joseph Stringer64% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | -48.99% | Needham | Joseph Stringer64% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 04/18/2023 | Buy Now | -48.99% | Needham | Joseph Stringer64% | → $32 | Reiterates | → Buy | Get Alert |
| 03/02/2023 | Buy Now | -55.36% | Morgan Stanley | Jeffrey Hung51% | $26 → $28 | Maintains | Equal-Weight | Get Alert |
| 03/02/2023 | Buy Now | -10.73% | Canaccord Genuity | Whitney Ijem56% | $52 → $56 | Maintains | Buy | Get Alert |
| 03/02/2023 | Buy Now | -28.26% | Goldman Sachs | Corinne Jenkins47% | $40 → $45 | Maintains | Buy | Get Alert |
| 03/02/2023 | Buy Now | -44.21% | Ladenburg Thalmann | Michael Higgins45% | → $35 | Reiterates | → Buy | Get Alert |
| 03/02/2023 | Buy Now | -48.99% | Needham | Joseph Stringer64% | → $32 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | Buy Now | -36.23% | Goldman Sachs | Corinne Jenkins47% | $35 → $40 | Maintains | Buy | Get Alert |
| 01/18/2023 | Buy Now | — | Canaccord Genuity | Whitney Ijem56% | — | Assumes | → Buy | Get Alert |
| 11/10/2022 | Buy Now | -44.21% | Goldman Sachs | Graig Suvannavejh51% | $31 → $35 | Maintains | Buy | Get Alert |
| 11/09/2022 | Buy Now | -58.55% | Morgan Stanley | Jeffrey Hung51% | $16 → $26 | Maintains | Equal-Weight | Get Alert |
| 09/08/2022 | Buy Now | -50.58% | Goldman Sachs | Corinne Jenkins47% | $28 → $31 | Maintains | Buy | Get Alert |
| 08/08/2022 | Buy Now | -55.36% | Goldman Sachs | Corinne Jenkins47% | → $28 | Upgrade | Neutral → Buy | Get Alert |
| 08/05/2022 | Buy Now | -68.12% | B of A Securities | Tazeen Ahmad56% | $8 → $20 | Upgrade | Underperform → Neutral | Get Alert |
| 08/03/2022 | Buy Now | -74.49% | Morgan Stanley | Jeffrey Hung51% | $8 → $16 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | Buy Now | -87.25% | Morgan Stanley | Jeffrey Hung51% | $4 → $8 | Maintains | Equal-Weight | Get Alert |
| 07/13/2022 | Buy Now | -90.44% | Goldman Sachs | Graig Suvannavejh51% | $4 → $6 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Rhythm Pharmaceuticals (RYTM) stock?
The latest price target for Rhythm Pharmaceuticals (NASDAQ:RYTM) was reported by JMP Securities on June 26, 2025. The analyst firm set a price target for $84.00 expecting RYTM to rise to within 12 months (a possible 33.91% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Rhythm Pharmaceuticals (RYTM)?
The latest analyst rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) was provided by JMP Securities, and Rhythm Pharmaceuticals reiterated their market outperform rating.
When was the last upgrade for Rhythm Pharmaceuticals (RYTM)?
The last upgrade for Rhythm Pharmaceuticals Inc happened on December 19, 2023 when Morgan Stanley raised their price target to $55. Morgan Stanley previously had an equal-weight for Rhythm Pharmaceuticals Inc.
When was the last downgrade for Rhythm Pharmaceuticals (RYTM)?
The last downgrade for Rhythm Pharmaceuticals Inc happened on May 8, 2024 when B of A Securities changed their price target from $49 to $42 for Rhythm Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Rhythm Pharmaceuticals (RYTM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rhythm Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rhythm Pharmaceuticals was filed on June 26, 2025 so you should expect the next rating to be made available sometime around June 26, 2026.
Is the Analyst Rating Rhythm Pharmaceuticals (RYTM) correct?
While ratings are subjective and will change, the latest Rhythm Pharmaceuticals (RYTM) rating was a reiterated with a price target of $84.00 to $84.00. The current price Rhythm Pharmaceuticals (RYTM) is trading at is $62.73, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
